CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL 11.9 MCG
ALPROSTADIL : 11.9 MCG · DIN 02215179 · PFIZER CANADA ULC
Health Canada status: CANCELLED POST MARKET
What is CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL?
CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL 11.9 MCG contains ALPROSTADIL : 11.9 MCG. It is listed in the Health Canada Drug Product Database under DIN 02215179, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for INTRACAVERNOSAL administration. Health Canada currently lists it as cancelled post market, status dated 02-Aug-2006. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL used for?
CAVERJECT STERILE POWDER (alprostadil) is indicated for the intracavernosal treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology. Intracavernosal CAVERJECT STERILE POWDER may also be useful as an adjunct to diagnostic tests in the diagnosis of erectile dysfunction.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02215179 |
|---|---|
| Brand name | CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL |
| Generic / active ingredient | ALPROSTADIL : 11.9 MCG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 11.9 MCG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRACAVERNOSAL |
| Schedule | Prescription |
| ATC code | G04BE01 ALPROSTADIL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Aug-2006 |
How is it stored and handled?
null
How is it supplied?
A vial of CAVERJECT STERILE POWDER delivers one dose only. Instructions for proper disposal of the syringe, needle and vial should be followed (see PATIENT MEDICATION INFORMATION ). CAVERJECT STERILE POWDER is available in cartons containing 5 cases. Each case contains: a single dose vial of 20 mcg CAVERJECT STERILE POWDER sterile powder, 1 mL pre-filled syringe of BWFI diluent, a 27-gauge, 0.5-inch needle, 2 alcohol swabs and Patient Administration Leaflet. These cases are fitted with a lock designed for safe and convenient disposal of the contents after use.
What can be used instead?
Other Canadian products sharing ATC code G04BE01 ALPROSTADIL. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CAVERJECT STERILE POWDER | 20 MCG | LIQUID ; KIT ; POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02215756 |
| CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL | 20 MCG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02215187 |
| CAVERJECT STERILE POWDER - KIT 11.9MCG /VIAL | 99.1 % | POWDER FOR SOLUTION ; KIT ; LIQUID | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02215748 |
| MUSE | 1000 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238595 |
| MUSE | 125 MCG | SUPPOSITORY | PALADIN PHARMA INC. | CANCELLED PRE MARKET | DIN 02238592 |
| MUSE | 250 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238593 |
| MUSE | 500 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238594 |
| VITAROS | 220 MCG / 100 MG | CREAM | BGP PHARMA ULC | APPROVED | DIN 02359413 |
| VITAROS | 330 MCG / 100 MG | CREAM | BGP PHARMA ULC | APPROVED | DIN 02359421 |
Who else supplies ALPROSTADIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALPROSTADIL appears in 39 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.